Authors: Queille-Roussel, C Duteil, L Parneix-Spake, A Arsonnaud, S Rizova, E

Citation: C. Queille-roussel et al., The safety of calcitriol 3 mu g/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity, EUR J DERM, 11(3), 2001, pp. 219-224

Authors: Queille-Roussel, C Poncet, M Mesaros, S Clucas, A Baker, M Soloff, AM

Citation: C. Queille-roussel et al., Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel, CLIN THER, 23(2), 2001, pp. 205-212

Authors: Queille-Roussel, C Paul, C Duteil, L Lefebvre, MC Rapatz, G Zagula, M Ortonne, JP

Citation: C. Queille-roussel et al., The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study, BR J DERM, 144(3), 2001, pp. 507-513

Authors: Queille-Roussel, C Graeber, M Thurston, M Lachapelle, JM Decroix, J de Cuyper, C Ortonne, JP

Citation: C. Queille-roussel et al., SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge, CONTACT DER, 42(6), 2000, pp. 349-350